Discontinued — last reported Q2 '24
ResMed Sleep and Respiratory Care — Goodwill (note 5) increased by 1.7% to $757.53M in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $670.12M to $757.53M. Over 3 years (FY 2021 to FY 2024), Sleep and Respiratory Care — Goodwill (note 5) shows an upward trend with a 5.8% CAGR.
An increase indicates recent M&A activity, while a decrease may signal impairment charges due to underperforming acquisitions.
Represents the intangible asset value recorded when the company acquires another business within the sleep and respirato...
Common in medical device companies that grow through inorganic expansion; peers often report this as 'Goodwill' on the balance sheet.
rmd_segment_sleep_and_respiratory_care_goodwill_note_5| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $633.18M | $627.32M | $656.74M | $651.60M | $641.72M | $644.13M | $667.26M | $669.70M | $670.12M | $736.39M | $751.84M | $744.72M | $757.53M |
| QoQ Change | — | -0.9% | +4.7% | -0.8% | -1.5% | +0.4% | +3.6% | +0.4% | +0.1% | +9.9% | +2.1% | -0.9% | +1.7% |
| YoY Change | — | — | — | — | +1.3% | +2.7% | +1.6% | +2.8% | +4.4% | +14.3% | +12.7% | +11.2% | +13.0% |